<DOC>
	<DOCNO>NCT00787813</DOCNO>
	<brief_summary>The aim study evaluate effect N-acetyl cysteine ( NAC ) pregnancy outcome woman undergo cervical cerclage cervical insufficiency .</brief_summary>
	<brief_title>N-Acetyl Cysteine After Cervical Cerclage</brief_title>
	<detailed_description>A randomize controlled clinical trial carry university-affiliated tertiary center.Participating woman randomize two group : Group A give oral daily dose 0.6 g NAC effervescent form ; group B , serve control , receive NAC.The two group compare accord pregnancy outcome .</detailed_description>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>woman history suggestive cervical insufficiency together ultrasound finding suggestive cervical insufficiency undergo elective cervical cerclage 11th 12th gestational week . singelton viable fetus woman test positive bacterial vaginosis woman currently threaten abortion ( vaginal bleeding uterinecramps ) age old 35 year younger 20 year unwillingness participate irregular and/or uncertain menstrual date rupture membrane previous cesarean delivery possible risk preterm birth current previous pregnancy twin pregnancy , IUFD , malpresentation , know fetal anomaly , progesterone heparin treatment current pregnancy , hypertension , and/or seizure disorder . woman contra indication cervical cerclage anesthesia .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>N-acetyl cysteine ( NAC )</keyword>
	<keyword>Cervical cerclage</keyword>
	<keyword>cervical cerclage cervical insufficiency</keyword>
</DOC>